Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Ann Rheum Dis. Published Online First: 6 August 2008. doi:10.1136/ard.2008.092312
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Guthrie, K. A.
Right arrow Articles by Nelson, J L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guthrie, K. A.
Right arrow Articles by Nelson, J L.

Concise Report

Non inherited maternal HLA antigens in susceptibility to familial rheumatoid arthritis

Katherine A. Guthrie 1*, Natalia R Tishkevich 2 and J Lee Nelson 1

1 Fred Hutchinson Cancer Research Center, United States
2 University of Washington, United States

* To whom correspondence should be addressed. E-mail: kguthrie{at}fhcrc.org.

Accepted 26 July 2008


*  Abstract

Objectives: Some rheumatoid arthritis (RA) patients lack RA-associated HLA alleles. Prior studies investigated non-inherited maternal HLA alleles (NIMA) in RA risk with conflicting results.

Methods: We examined NIMA in a large cohort of families from the North American Rheumatoid Arthritis Consortium.

Results Among 620 patients with one or both parents HLA-genotyped, RA patients informative for analysis included 176 without HLA-DRB1*04 and 86 without the HLA shared epitope (SE). The frequency of NIMA encoding HLA-DR4 or the SE was compared to the non-inherited paternal allele (NIPA). DR4-encoding NIMA vs. NIPA revealed no significant difference (27% vs. 20%). However, parity is known to modulate RA risk and analyses stratified by sex and age of onset showed significant variation among women. Interestingly, among women with onset <45 years DR4-encoding NIMA was increased compared to NIPA; among women >45 years at onset the reverse was observed (31% vs. 16% compared to 10% vs. 60%, p=0.008). DR4 encoding NIMA vs. NIPA did not differ in men. The SE did not differ in men or women.

Conclusions: Risk of RA was associated with HLA-DR4 encoding NIMA in younger-onset women but not in older-onset women or men. These observations could help explain conflicting prior results of NIMA in RA.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism